Literature DB >> 32778601

Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.

Stefan Schandelmaier1, Matthias Briel2, Ravi Varadhan2, Christopher H Schmid2, Niveditha Devasenapathy2, Rodney A Hayward2, Joel Gagnier2, Michael Borenstein2, Geert J M G van der Heijden2, Issa J Dahabreh2, Xin Sun2, Willi Sauerbrei2, Michael Walsh2, John P A Ioannidis2, Lehana Thabane2, Gordon H Guyatt2.   

Abstract

BACKGROUND: Most randomized controlled trials (RCTs) and meta-analyses of RCTs examine effect modification (also called a subgroup effect or interaction), in which the effect of an intervention varies by another variable (e.g., age or disease severity). Assessing the credibility of an apparent effect modification presents challenges; therefore, we developed the Instrument for assessing the Credibility of Effect Modification Analyses (ICEMAN).
METHODS: To develop ICEMAN, we established a detailed concept; identified candidate credibility considerations in a systematic survey of the literature; together with experts, performed a consensus study to identify key considerations and develop them into instrument items; and refined the instrument based on feedback from trial investigators, systematic review authors and journal editors, who applied drafts of ICEMAN to published claims of effect modification.
RESULTS: The final instrument consists of a set of preliminary considerations, core questions (5 for RCTs, 8 for meta-analyses) with 4 response options, 1 optional item for additional considerations and a rating of credibility on a visual analogue scale ranging from very low to high. An accompanying manual provides rationales, detailed instructions and examples from the literature. Seventeen potential users tested ICEMAN; their suggestions improved the user-friendliness of the instrument.
INTERPRETATION: The Instrument for assessing the Credibility of Effect Modification Analyses offers explicit guidance for investigators, systematic reviewers, journal editors and others considering making a claim of effect modification or interpreting a claim made by others.
© 2020 Joule Inc. or its licensors.

Mesh:

Year:  2020        PMID: 32778601      PMCID: PMC7829020          DOI: 10.1503/cmaj.200077

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  42 in total

1.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

2.  Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?

Authors:  Adrián V Hernández; Eric Boersma; Gordon D Murray; J Dik F Habbema; Ewout W Steyerberg
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

Review 3.  A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses.

Authors:  Laura Koopman; Geert J M G van der Heijden; Paul P Glasziou; Diederick E Grobbee; Maroeska M Rovers
Journal:  J Clin Epidemiol       Date:  2007-08-01       Impact factor: 6.437

4.  How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study.

Authors:  Ewoud Schuit; Alvin H Li; John P A Ioannidis
Journal:  Int J Epidemiol       Date:  2019-04-01       Impact factor: 7.196

5.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.

Authors:  Pablo Alonso-Coello; Holger J Schünemann; Jenny Moberg; Romina Brignardello-Petersen; Elie A Akl; Marina Davoli; Shaun Treweek; Reem A Mustafa; Gabriel Rada; Sarah Rosenbaum; Angela Morelli; Gordon H Guyatt; Andrew D Oxman
Journal:  BMJ       Date:  2016-06-28

Review 7.  Multiplicity issues in exploratory subgroup analysis.

Authors:  Ilya Lipkovich; Alex Dmitrienko; Christoph Muysers; Bohdana Ratitch
Journal:  J Biopharm Stat       Date:  2017-11-27       Impact factor: 1.051

8.  Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; P de Leeuw; J F de Plaen; M Deruyttere; A De Schaepdryver; C Dollery
Journal:  J Hypertens Suppl       Date:  1986-12

9.  Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis.

Authors:  Patrick Royston; Willi Sauerbrei
Journal:  Stat Med       Date:  2013-04-12       Impact factor: 2.373

10.  Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis.

Authors:  Patrick Royston; Willi Sauerbrei
Journal:  Stat Med       Date:  2014-09-22       Impact factor: 2.373

View more
  45 in total

1.  Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?

Authors:  Michael Walsh
Journal:  J Am Soc Nephrol       Date:  2022-01-24       Impact factor: 10.121

2.  Noninvasive respiratory support following extubation in critically ill adults: a systematic review and network meta-analysis.

Authors:  Andrew J E Seely; Bram Rochwerg; Shannon M Fernando; Alexandre Tran; Behnam Sadeghirad; Karen E A Burns; Eddy Fan; Daniel Brodie; Laveena Munshi; Ewan C Goligher; Deborah J Cook; Robert A Fowler; Margaret S Herridge; Pierre Cardinal; Samir Jaber; Morten Hylander Møller; Arnaud W Thille; Niall D Ferguson; Arthur S Slutsky; Laurent J Brochard
Journal:  Intensive Care Med       Date:  2021-11-25       Impact factor: 17.440

3.  Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials.

Authors:  Willi Sauerbrei; Patrick Royston
Journal:  BMC Med Res Methodol       Date:  2022-04-06       Impact factor: 4.615

4.  Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Jennie Johnstone; Maureen Meade; François Lauzier; John Marshall; Erick Duan; Joanna Dionne; Yaseen M Arabi; Diane Heels-Ansdell; Lehana Thabane; Daphnee Lamarche; Michael Surette; Nicole Zytaruk; Sangeeta Mehta; Peter Dodek; Lauralyn McIntyre; Shane English; Bram Rochwerg; Tim Karachi; William Henderson; Gordon Wood; Daniel Ovakim; Margaret Herridge; John Granton; M Elizabeth Wilcox; Alberto Goffi; Henry T Stelfox; Daniel Niven; John Muscedere; François Lamontagne; Frédérick D'Aragon; Charles St-Arnaud; Ian Ball; Dave Nagpal; Martin Girard; Pierre Aslanian; Emmanuel Charbonney; David Williamson; Wendy Sligl; Jan Friedrich; Neill K Adhikari; François Marquis; Patrick Archambault; Kosar Khwaja; Arnold Kristof; James Kutsogiannis; Ryan Zarychanski; Bojan Paunovic; Brenda Reeve; François Lellouche; Paul Hosek; Jennifer Tsang; Alexandra Binnie; Sébastien Trop; Osama Loubani; Richard Hall; Robert Cirone; Steve Reynolds; Paul Lysecki; Eyal Golan; Rodrigo Cartin-Ceba; Robert Taylor; Deborah Cook
Journal:  JAMA       Date:  2021-09-21       Impact factor: 56.272

5.  Special considerations in randomized trials investigating neonatal surgical treatments.

Authors:  Martin L Blakely; Matthew A Rysavy; Kevin P Lally; Barry Eggleston; Claudia Pedroza; Jon E Tyson
Journal:  Semin Perinatol       Date:  2022-06-10       Impact factor: 3.311

6.  Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials.

Authors:  Aliyu Tijani Jibril; Ahmad Jayedi; Sakineh Shab-Bidar
Journal:  Endocr Connect       Date:  2022-09-26       Impact factor: 3.221

Review 7.  The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Seyyed Mostafa Arabi; Mahla Chambari; Mahsa Malek-Ahmadi; Leila Sadat Bahrami; Vahid Hadi; Manfredi Rizzo; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2022-08-21       Impact factor: 5.093

8.  WHO COVID-19 therapeutic guidelines.

Authors:  Bram Rochwerg; Thomas Agoritsas; Janet Diaz; Lisa Askie
Journal:  Lancet       Date:  2021-07-10       Impact factor: 79.321

9.  Initial Laparotomy Versus Peritoneal Drainage in Extremely Low Birthweight Infants With Surgical Necrotizing Enterocolitis or Isolated Intestinal Perforation: A Multicenter Randomized Clinical Trial.

Authors:  Martin L Blakely; Jon E Tyson; Kevin P Lally; Susan R Hintz; Barry Eggleston; David K Stevenson; Gail E Besner; Abhik Das; Robin K Ohls; William E Truog; Leif D Nelin; Brenda B Poindexter; Claudia Pedroza; Michele C Walsh; Barbara J Stoll; Rachel Geller; Kathleen A Kennedy; Reed A Dimmitt; Waldemar A Carlo; C Michael Cotten; Abbot R Laptook; Krisa P Van Meurs; Kara L Calkins; Gregory M Sokol; Pablo J Sanchez; Myra H Wyckoff; Ravi M Patel; Ivan D Frantz; Seetha Shankaran; Carl T D'Angio; Bradley A Yoder; Edward F Bell; Kristi L Watterberg; Colin A Martin; Carroll M Harmon; Henry Rice; Arlet G Kurkchubasche; Karl Sylvester; James C Y Dunn; Troy A Markel; Diana L Diesen; Amina M Bhatia; Alan Flake; Walter J Chwals; Rebeccah Brown; Kathryn D Bass; Shawn D St Peter; Christina M Shanti; Walter Pegoli; David Skarda; Joel Shilyansky; David G Lemon; Ricardo A Mosquera; Myriam Peralta-Carcelen; Ricki F Goldstein; Betty R Vohr; Isabell B Purdy; Abbey C Hines; Nathalie L Maitre; Roy J Heyne; Sara B DeMauro; Elisabeth C McGowan; Kimberly Yolton; Howard W Kilbride; Girija Natarajan; Kelley Yost; Sarah Winter; Tarah T Colaizy; Matthew M Laughon; Satyanarayana Lakshminrusimha; Rosemary D Higgins
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 13.787

Review 10.  Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis.

Authors:  Zhikang Ye; Ying Wang; Long Ge; Gordon H Guyatt; David Collister; Waleed Alhazzani; Sean M Bagshaw; Emilie P Belley-Cote; Fang Fang; Liangying Hou; Philipp Kolb; Francois Lamontagne; Simon Oczkowski; Lonnie Pyne; Christian Rabbat; Matt Scaum; Borna Tadayon Najafabadi; Wimonchat Tangamornsuksan; Ron Wald; Qi Wang; Michael Walsh; Liang Yao; Linan Zeng; Abdullah Mohammed Algarni; Rachel J Couban; Paul Elias Alexander; Bram Rochwerg
Journal:  Crit Care Explor       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.